Osonuga, Ayokunle, Olawade, David B., Gore, Manisha, Rotifa, Oluwayomi B., Egbon, Eghosasere, Chinwah, Viviane, Boussios, Stergios (2025) Generative artificial intelligence in predictive analysis of diabetes and its complications: a narrative review. Annals of Translational Medicine, 13 (5). Article Number 59. ISSN 2305-5839. (doi:10.21037/atm-25-62) (KAR id:112107)
|
PDF
Publisher pdf
Language: English
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
|
|
|
Download this file (PDF/499kB) |
Preview |
| Request a format suitable for use with assistive technology e.g. a screenreader | |
| Official URL: https://doi.org/10.21037/atm-25-62 |
|
Abstract
Diabetes mellitus (DM), particularly type 2 diabetes (T2D), represents a significant global health crisis, often complicated by severe and progressive conditions such as retinopathy, neuropathy, and cardiovascular disease. Traditional diagnostic approaches frequently detect these complications at advanced stages, limiting the opportunity for early, effective intervention. This review aims to examine how recent advancements in generative artificial intelligence (AI), particularly large language models (LLMs), can transform diabetes management by enabling earlier detection and more personalized interventions. A narrative review was conducted to evaluate the current literature on the application of generative AI and LLMs in diabetes care. The review focused on how these technologies analyse multi-dimensional datasets, including medical imaging, electronic health records (EHRs), genetic profiles, and lifestyle factors, and how they process both structured and unstructured data to enhance predictive analytics and risk stratification for diabetes complications. Generative AI models have demonstrated significant promise in detecting hidden trends and early risk factors for complications such as diabetic retinopathy and neuropathy, often before clinical symptoms manifest. LLMs enhance predictive performance by synthesising unstructured data sources, such as physician notes and patient-reported outcomes, with clinical datasets. Despite limitations concerning data quality, model transparency, and ethical concerns surrounding data privacy, these technologies offer powerful tools for proactive disease monitoring and personalized care. Generative AI and LLMs are poised to redefine diabetes management by enabling earlier detection of complications and personalised treatment strategies. Their integration into clinical decision support systems (CDSS) and precision medicine frameworks may reduce the global burden of diabetes, improve patient outcomes, and shift care from reactive to preventative.
| Item Type: | Article |
|---|---|
| DOI/Identification number: | 10.21037/atm-25-62 |
| Uncontrolled keywords: | large language models (LLMs), diabetes mellitus (DM), predictive analytics, personalized medicine, Generative artificial intelligence (generative AI) |
| Subjects: | R Medicine |
| Institutional Unit: | Schools > Kent and Medway Medical School |
| Former Institutional Unit: |
There are no former institutional units.
|
| Funders: | University of Kent (https://ror.org/00xkeyj56) |
| SWORD Depositor: | JISC Publications Router |
| Depositing User: | JISC Publications Router |
| Date Deposited: | 18 Feb 2026 10:34 UTC |
| Last Modified: | 25 Feb 2026 04:15 UTC |
| Resource URI: | https://kar.kent.ac.uk/id/eprint/112107 (The current URI for this page, for reference purposes) |
- Link to SensusAccess
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):

https://orcid.org/0000-0002-2512-6131
Altmetric
Altmetric